Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Thurn KT"'
Publikováno v:
Breast cancer research : BCR, vol 17, iss 1
INTRODUCTION: The emergence of hormone therapy resistance, despite continued expression of the estrogen receptor (ER), is a major challenge to curing breast cancer. Recent clinical studies suggest that epigenetic modulation by histone deacetylase (HD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9fc94378afb8fecb9912c8202b81bafb
https://escholarship.org/uc/item/6nw18482
https://escholarship.org/uc/item/6nw18482
Publikováno v:
Munster, Pamela; Thomas, S; Thurn, KT; Raha, P; Chen, S; & Munster, PN. (2013). Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/5s30x26p
Hormonal therapy resistance remains a considerable barrier in the treatment of breast cancer. Activation of the Akt-PI3K-mTOR pathway plays an important role in hormonal therapy resistance. Our recent preclinical and clinical studies showed that the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::b7b11753071df0ac3714cfb6db1be3b3
http://www.escholarship.org/uc/item/5s30x26p
http://www.escholarship.org/uc/item/5s30x26p
Autor:
Thomas S; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Aggarwal R; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Jahan T; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Ryan C; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Troung T; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Cripps AM; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Raha P; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Thurn KT; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Chen S; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Grabowsky JA; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Park J; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Hwang J; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Daud A; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA., Munster PN; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA pamela.munster@ucsf.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 May; Vol. 27 (5), pp. 947-52. Date of Electronic Publication: 2016 Feb 21.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2015 Feb 25; Vol. 17, pp. 26. Date of Electronic Publication: 2015 Feb 25.
Autor:
Thurn KT; Corresponding Author: Pamela N. Munster, Division of Hematology and Oncology, Department of Medicine, University of California, 1600 Divisadero, Room A719, Box 1711, San Francisco, CA 94143. pmunster@medicine.ucsf.edu., Thomas S, Raha P, Qureshi I, Munster PN
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2013 Oct; Vol. 12 (10), pp. 2078-87. Date of Electronic Publication: 2013 Aug 12.
Autor:
Thomas S; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America., Thurn KT, Raha P, Chen S, Munster PN
Publikováno v:
PloS one [PLoS One] 2013 Jul 09; Vol. 8 (7), pp. e68973. Date of Electronic Publication: 2013 Jul 09 (Print Publication: 2013).
Autor:
Thomas S; Division of Hematology and Oncology, University of California, San Francisco, CA 94143, USA., Thurn KT, Biçaku E, Marchion DC, Münster PN
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2011 Nov; Vol. 130 (2), pp. 437-47. Date of Electronic Publication: 2011 Feb 05.
Autor:
Munster PN; Division of Hematology and Oncology, University of California, San Francisco, 1600 Divisadero, Rm A719 Box 1711, San Francisco, CA 94143, USA. pmunster@medicine.ucsf.edu, Thurn KT, Thomas S, Raha P, Lacevic M, Miller A, Melisko M, Ismail-Khan R, Rugo H, Moasser M, Minton SE
Publikováno v:
British journal of cancer [Br J Cancer] 2011 Jun 07; Vol. 104 (12), pp. 1828-35. Date of Electronic Publication: 2011 May 10.
Autor:
Thurn KT; Department of Radiation Oncology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA., Arora H, Paunesku T, Wu A, Brown EM, Doty C, Kremer J, Woloschak G
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2011 Apr; Vol. 7 (2), pp. 123-30. Date of Electronic Publication: 2010 Sep 29.
Autor:
Thurn KT; Department of Medicine, Hematology/Oncology Division. University of California-San Francisco, 1600 Divisadero Street, San Francisco, CA 94115, USA., Thomas S, Moore A, Munster PN
Publikováno v:
Future oncology (London, England) [Future Oncol] 2011 Feb; Vol. 7 (2), pp. 263-83.